Eventide Asset Management – CRINETICS PHARMACEUTICALS IN

Eventide Asset Management ownership history of CRINETICS PHARMACEUTICALS IN
QuarterValueSharesWeighting
Q1 2021$3,685
-34.7%
241,140
-39.7%
0.06%
-36.8%
Q4 2020$5,644
-73.3%
400,000
-70.3%
0.09%
-78.9%
Q3 2020$21,107
-10.6%
1,347,0000.0%0.41%
-19.5%
Q2 2020$23,599
69.5%
1,347,000
42.2%
0.51%
13.7%
Q1 2020$13,921
-41.4%
947,0000.0%0.45%
-32.6%
Q4 2019$23,760
66.8%
947,0000.0%0.67%
42.0%
Q3 2019$14,243
-29.1%
947,000
17.8%
0.47%
-22.9%
Q2 2019$20,096
129.9%
803,839
109.3%
0.61%
103.0%
Q1 2019$8,740
136.5%
384,000
211.6%
0.30%
83.5%
Q4 2018$3,696
4.7%
123,2250.0%0.16%
26.2%
Q3 2018$3,530123,2250.13%